Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson's Disease Risk

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Alpha-synuclein accumulation is a hallmark of Parkinson's disease (PD), primarily studied in neurons.
• The gene SNCA mutations and expression alterations are PD risk factors, affecting diverse cell types.
• Microglia, the CNS immune cells, are increasingly recognized as influenced by alpha-synuclein.

Purpose of the Study:

• To review the physiological roles of alpha-synuclein in non-neuronal cells, particularly microglia.
• To explore how altered alpha-synuclein expression impacts microglial functions in PD.
• To connect early-life effects of alpha-synuclein to PD risk.

Main Methods:

• Literature review of studies on alpha-synuclein in neurons and non-neuronal cells.
• Analysis of genetic studies linking SNCA to PD risk.
• Synthesis of research on alpha-synuclein's effects on microglial differentiation, immunity, and vesicle formation.

Main Results:

• Alpha-synuclein influences hematopoiesis, affecting microglia development.
• Altered alpha-synuclein levels impact microglia immune responses and cytokine release.
• SNARE-mediated vesicle formation efficiency in microglia is modulated by alpha-synuclein levels.

Conclusions:

• Alpha-synuclein has significant physiological roles in microglia, extending beyond its known neuronal functions.
• Dysregulation of alpha-synuclein in microglia may contribute to PD pathogenesis from early developmental stages.
• Further research is needed to fully elucidate alpha-synuclein's role in non-neuronal cells during PD.